Birdwatch Note Rating
2023-03-15 20:54:03 UTC - NOT_HELPFUL
Rated by Participant: AC154D5D9DD4B95EBD0A9C603ED8F6BEF41E162185A31AC19D702B3887789008
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details